# Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"

> **NCT03954652** · NA · COMPLETED · sponsor: **University Hospital Tuebingen** · enrollment: 1350 (actual)

## Conditions studied

- Rare Diseases
- Genetic Predisposition

## Interventions

- **GENETIC:** WGS-Diagnostic

## Key facts

- **NCT ID:** NCT03954652
- **Lead sponsor:** University Hospital Tuebingen
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-10-01
- **Primary completion:** 2022-10-01
- **Final completion:** 2022-10-01
- **Target enrollment:** 1350 (ACTUAL)
- **Last updated:** 2022-10-18


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03954652

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03954652, "Whole Genome Trio Sequencing as a Standard Routine Test in Patients With Rare Diseases - "GENOME FIRST APPROACH"". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03954652. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*